Ladrx Corporation logo
VerifiedBiotechnology Research· Founded 1985

Ladrx Corporation

LadRx Corporation (OTCQB: LADX) is a biopharmaceutical company with expertise in discovering and developing new therapeutics principally to treat patients with cancer. LadRx’s most recent advanced drug conjugate, aldoxorubicin, is an improved version of the widely used anti-cancer drug doxorubicin and has been out-licensed to ImmunityBio, Inc. In addition, LadRx’s drug candidate, arimoclomol, was sold to Orphazyme A/S (now Zevra Therapeutics) in exchange for milestone payments and royalties. Zevra is developing arimoclomol and is currently focused on Niemann-Pick disease Type C (NPC).

7-day free trial · no credit card

Employees1 to 10Founded year1985Websiteladrxcorp.comLinkedIn profileLinkedIn

Verified contacts

12

available on Kipplo

LinkedIn employees

1 to 10

headcount range

Open roles

no listings

Distinct roles

11

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 12 verified contacts at Ladrx Corporation

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

12 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Ladrx Corporation

11 distinct titles indexed · top 10 shown.

  • 2chief medical officer
  • 1accountant
  • 1admin asst
  • 1administrative assistant
  • 1cfo
  • 1controller
  • 1cpa
  • 1director of biology
  • 1director of chemistry
  • 1executive assistant office manager
  • +1more titles

Sign up to unlock all 12 contacts at Ladrx Corporation

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 12 verified contacts at Ladrx Corporation

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Ladrx Corporation | Kipplo Discover